Related references
Note: Only part of the references are listed.Understanding the molecular basis of cardiomyopathy
Marie-Louise Bang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2022)
Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis
Hiroki Kitakata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2022)
The Heart of the Alzheimer's: A Mindful View of Heart Disease
Alessandro Evangelisti et al.
FRONTIERS IN PHYSIOLOGY (2021)
Systematic Evaluations of Doxorubicin-Induced Toxicity in Rats Based on Metabolomics
Chunmei Geng et al.
ACS OMEGA (2021)
The Complex and Diverse Genetic Architecture of Dilated Cardiomyopathy
Ray E. Hershberger et al.
CIRCULATION RESEARCH (2021)
Connexins in the Heart: Regulation, Function and Involvement in Cardiac Disease
Antonio Rodriguez-Sinovas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
Pushkar Singh Rawat et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Striated Preferentially Expressed Protein Kinase (SPEG) in Muscle Development, Function, and Disease
Shiyu Luo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity
Miguel Anjos et al.
LIFE SCIENCES (2021)
Analysis of Models of Doxorubicin-Induced Cardiomyopathy in Rats and Mice. A Modern View From the Perspective of the Pathophysiologist and the Clinician
Ekaterina Yu Podyacheva et al.
FRONTIERS IN PHARMACOLOGY (2021)
Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy
Kendall B. Wallace et al.
CIRCULATION RESEARCH (2020)
Early detection of doxorubicin-induced cardiotoxicity in rats by its cardiac metabolic signature assessed with hyperpolarized MRI
Kerstin N. Timm et al.
COMMUNICATIONS BIOLOGY (2020)
Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision
Ashif Iqubal et al.
LIFE SCIENCES (2019)
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
Qiang Gao et al.
CELL (2019)
MoMo: discovery of statistically significant post-translational modification motifs
Alice Cheng et al.
BIOINFORMATICS (2019)
Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy
Oscar Calvillo-Arguelles et al.
CANADIAN JOURNAL OF CARDIOLOGY (2019)
Metabolic remodelling in heart failure
Edoardo Bertero et al.
NATURE REVIEWS CARDIOLOGY (2018)
Updates in Anthracycline-Mediated Cardiotoxicity
Canan G. Nebigil et al.
FRONTIERS IN PHARMACOLOGY (2018)
Identification of Estrogen-Related Receptor α Agonists in the Tox21 Compound Library
Caitlin Lynch et al.
ENDOCRINOLOGY (2018)
Divergent Role of Estrogen-Related Receptor alpha in Lipid- and Fasting-Induced Hepatic Steatosis in Mice
Wafa B'chir et al.
ENDOCRINOLOGY (2018)
Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies
Roberta Florido et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Dilated Cardiomyopathy Genetic Determinants and Mechanisms
Elizabeth M. McNally et al.
CIRCULATION RESEARCH (2017)
Phosphorylation at Connexin43 Serine-368 Is Necessary for Myocardial Conduction During Metabolic Stress
Michelle M. J. Nassal et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2016)
Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure
Kenneth C. Bedi et al.
CIRCULATION (2016)
Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice
Laura K. Schnackenberg et al.
JOURNAL OF APPLIED TOXICOLOGY (2016)
1H NMR based metabolomic profiling revealed doxorubicin-induced systematic alterations in a rat model
Qian-Yun Niu et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease
John R. Ussher et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
The extracellular matrix: Tools and insights for the omics era
Alexandra Naba et al.
MATRIX BIOLOGY (2016)
GAM: a web-service for integrated transcriptional and metabolic network analysis
Alexey A. Sergushichev et al.
NUCLEIC ACIDS RESEARCH (2016)
VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection
Markus Rasanen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Integrating immunometabolism and macrophage diversity
Maxim N. Artyomov et al.
SEMINARS IN IMMUNOLOGY (2016)
ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer
Genevieve Deblois et al.
NATURE COMMUNICATIONS (2016)
Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein
Lei Wang et al.
SCIENTIFIC REPORTS (2016)
Orphan Nuclear Receptor ERRα Controls Macrophage Metabolic Signaling and A20 Expression to Negatively Regulate TLR-Induced Inflammation
Jae-Min Yuk et al.
IMMUNITY (2015)
Cofilin-2 Phosphorylation and Sequestration in Myocardial Aggregates Novel Pathogenetic Mechanisms for Idiopathic Dilated Cardiomyopathy
Khaushik Subramanian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
The multiple universes of estrogen-related receptor α and γ in metabolic control and related diseases
Etienne Audet-Walsh et al.
ACTA PHARMACOLOGICA SINICA (2015)
A Metabolomic Study of Rats with Doxorubicin-Induced Cardiomyopathy and Shengmai Injection Treatment
Yu Chen et al.
PLOS ONE (2015)
Natriuretic peptides in cardiovascular diseases: current use and perspectives
Massimo Volpe et al.
EUROPEAN HEART JOURNAL (2014)
D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice
Esra A. Akbay et al.
GENES & DEVELOPMENT (2014)
Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism
Ioanna Andreadou et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
ERBB2 Deficiency Alters an E2F-1-Dependent Adaptive Stress Response and Leads to Cardiac Dysfunction
Marie-Claude Perry et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Genomic Models of Short-Term Exposure Accurately Predict Long-Term Chemical Carcinogenicity and Identify Putative Mechanisms of Action
Daniel Gusenleitner et al.
PLOS ONE (2014)
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Edward Y. Chen et al.
BMC BIOINFORMATICS (2013)
The PGC-1/ERR signaling axis in cancer
G. Deblois et al.
ONCOGENE (2013)
Loss of estrogen-related receptor a promotes hepatocarcinogenesis development via metabolic and inflammatory disturbances
Eui-Ju Hong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond
Genevieve Deblois et al.
NATURE REVIEWS CANCER (2013)
Cardiac phosphoproteome reveals cell signaling events involved in doxorubicin cardiotoxicity
Severine Gratia et al.
JOURNAL OF PROTEOMICS (2012)
Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline Chemotherapy An Observational Clinical Cohort Study
Sinziana Seicean et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
The Metabolic Regulator ERRα, a Downstream Target of HER2/IGF-1R, as a Therapeutic Target in Breast Cancer
Ching-yi Chang et al.
CANCER CELL (2011)
Thrombopoietin protects against doxorubicin-induced cardiomyopathy, improves cardiac function, and reversely alters specific signalling networks
Kathy Yuen-Yee Chan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Identification of Diaryl Ether-Based Ligands for Estrogen-Related Receptor α as Potential Antidiabetic Agents
Raymond J. Patch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Transforming growth factor (TGF)-β signaling in cardiac remodeling
Marcin Dobaczewski et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Potential Biomarkers in Mouse Myocardium of Doxorubicin-Induced Cardiomyopathy: A Metabonomic Method and Its Application
Guangguo Tan et al.
PLOS ONE (2011)
Global gene expression profiles of MT knockout and wild-type mice in the condition of doxorubicin-induced cardiomyopathy
Yi Shuai et al.
TOXICOLOGY LETTERS (2011)
Transcriptional Control of the ERBB2 Amplicon by ERRα and PGC-1β Promotes Mammary Gland Tumorigenesis
Genevieve Deblois et al.
CANCER RESEARCH (2010)
ErbB signaling in cardiac development and disease
Pablo Sanchez-Soria et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
KEA: kinase enrichment analysis
Alexander Lachmann et al.
BIOINFORMATICS (2009)
Improved visualization of protein consensus sequences by iceLogo
Niklaas Colaert et al.
NATURE METHODS (2009)
Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein
Ioanna Andreadou et al.
NMR IN BIOMEDICINE (2009)
Transcriptional Control of Energy Homeostasis by the Estrogen-Related Receptors
Vincent Giguere
ENDOCRINE REVIEWS (2008)
Nuclear receptor ERRα and coactivator PGC-1β are effectors of IFN-γ-induced host defense
Junichiro Sonoda et al.
GENES & DEVELOPMENT (2007)
The nuclear receptor ERRα is required for the bioenergetic and functional adaptation to cardiac pressure overload
Janice M. Huss et al.
CELL METABOLISM (2007)
Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRα and γ
Catherine R. Dufour et al.
CELL METABOLISM (2007)
PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites
Florian Gnad et al.
GENOME BIOLOGY (2007)
A curated compendium of phosphorylation motifs
Ramars Amanchy et al.
NATURE BIOTECHNOLOGY (2007)
An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets
D Schwartz et al.
NATURE BIOTECHNOLOGY (2005)
Modulation of Erbb2 signaling during development: a threshold level of Erbb2 signaling is required for development
R Chan et al.
DEVELOPMENT (2004)
Statistical significance for genomewide studies
JD Storey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha
JM Luo et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy
C Özcelik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
ErbB2 is essential in the prevention of dilated cardiomyopathy
SA Crone et al.
NATURE MEDICINE (2002)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
